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Although circulating hormones and inhibitory gamma-aminobutyric acid (GABA)-related
factors are known to affect mood, considerable knowledge gaps persist for biological
mechanisms underlying the female bias in mood disorders. Here, we combine human
and mouse studies to investigate sexual dimorphism in the GABA system in the context
of major depressive disorder (MDD) and then use a genetic model to dissect the role of
sex-related factors in GABA-related gene expression and anxiety-/depressive-like behaviors
in mice. First, using meta-analysis of gene array data in human postmortem brain (N =51
MDD subjects, 50 controls), we show that the previously reported down-regulation in
MDD of somatostatin (SST ), a marker of a GABA neuron subtype, is significantly greater in
women with MDD. Second, using gene co-expression network analysis in control human
subjects (N =214; two frontal cortex regions) and expression quantitative trait loci map-
ping (N =170 subjects), we show that expression of SST and the GABA-synthesizing
enzymes glutamate decarboxylase 67 (GAD67 ) and GAD65 are tightly co-regulated and
influenced by X-chromosome genetic polymorphisms.Third, using a rodent genetic model
[Four Core Genotypes (FCG) mice], in which genetic and gonadal sex are artificially dis-
sociated (N ≥12/group), we show that genetic sex (i.e., X/Y-chromosome) influences both
gene expression (lower Sst, Gad67, Gad65 in XY mice) and anxiety-like behaviors (higher
in XY mice). This suggests that in an intact male animal, the observed behavior repre-
sents the outcomes of male genetic sex increasing and male-like testosterone decreasing
anxiety-like behaviors. Gonadal sex was the only factor influencing depressive-like behavior
(gonadal males<gonadal females). Collectively, these combined human and mouse stud-
ies provide mechanistic insight into sexual dimorphism in mood disorders, and specifically
demonstrate an unexpected role of male-like factors (XY genetic sex) on GABA-related
genes and anxiety-like behaviors.
Keywords: GABA, genetic sex, mood, somatostatin, anxiety, depression
INTRODUCTION
Major depressive disorder (MDD) and anxiety disorders are dev-
astating, often chronic illnesses of altered mood regulation. These
disorders affect a significant portion of the population, with a pro-
jected lifetime risk of ∼23% for MDD and ∼32% for an anxiety
disorder (1). Although MDD and anxiety disorders are different
diagnoses, they are included in the broader definition of mood dis-
orders and findings from large-scale epidemiological studies across
cultures show high comorbidity and co-segregation within the
symptom dimension of high negative affect (i.e., internalization)
(2–4). MDD and anxiety disorders also share common genetic risk
(5), and symptom remission is observed in both conditions after
chronic treatment with selective serotonin reuptake inhibitors,
together suggesting the presence of common contributing bio-
logical factors. Women are twice as likely to be diagnosed with
MDD or an anxiety disorder, and anxiety symptoms are almost
always co-morbid with MDD in women, making the two difficult
to separate.
Adult hormone levels are linked to mood states, particularly
in relation to premenstrual dysphoric disorder and postpartum
depression (6). Rodent studies report links between circulating
hormone levels (“activational” hormone effects) and anxiety-
/depressive-like behaviors (7), although systematic reviews of
human studies do not report consistent associations (8). MDD
prevalence is higher in women across life stages and hormonal
states, indicating that structural or biological differences other
than adult circulating hormones place women at higher risk.
Indeed, permanent sexual dimorphism of the brain is estab-
lished by gonadal hormone exposure during critical developmen-
tal periods (“organizational” effects) and sex chromosome effects
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(“genetic” sex). Thus, sexual dimorphism in mood disorders could
be due to (i) activational effects of hormones in adulthood, (ii)
organizational effects of hormones during development (due to
different gonadal sex), (iii) differences in genetic sex, and/or (iv)
a combination of the above factors. We recently reported a par-
tial contribution of developmental hormone exposure to sexual
dimorphism in adult anxiety-/depressive-like behavior (referred to
as behavioral emotionality) in mice (9), suggesting that an alterna-
tive sex-related mechanism, potentially genetic sex, also influences
emotionality. Even though genetic sex has a predominant role
during development in determining gonadal sex, contributions
of X/Y-linked genes are ongoing throughout life.
Evidence from neuroimaging and postmortem neuroanatom-
ical and molecular studies suggest dysfunction in corticolimbic
emotion regulation centers of the brain in mood disorders (10).
This corticolimbic network includes the dorsolateral prefrontal
cortex (DLPFC), anterior cingulate cortex (ACC), hippocampus,
ventral striatum, anterior thalamic nuclei, and amygdala (10, 11).
Magnetic resonance spectroscopy studies reported decreased cor-
tical gamma-aminobutyric acid (GABA) content in MDD (12)
and correlation with emotional processing (13), while molecu-
lar studies further suggest reduced GABA-mediated inhibition
(14–16). Additionally, drugs that potentiate GABA function (e.g.,
benzodiazepines) are anxiolytic (17). Together these studies sup-
port the hypothesis of a deficit in inhibitory neurotransmission
in MDD, potentially related to low mood. These human findings
are supported by causal studies in mice, where mild reduction
in GABA-signaling is sufficient to induce anxiety-/depressive-like
behaviors (18). Interestingly, many studies have suggested that
hormones modulate mood by altering GABA transmission (19),
suggesting a potential link between sexual dimorphism in GABA
function and in risk for mood disorders. In human MDD subjects,
the amygdala (16), ACC (20, 21), and DLPFC (22) exhibit lower
markers of GABA interneurons, especially somatostatin (SST ), a
marker for the subtype of GABA neurons that target the den-
dritic compartment of pyramidal cells. Notably, reports of low
SST in MDD are often more robust in females (16, 21). In concert,
these findings suggest a GABA/SST -related cellular phenotype of
reduced dendritic inhibition in depression.
We tested here the hypothesis that genetic sex influences sex-
ual dimorphism in emotionality and associated gene expression.
Specifically, using both human postmortem brains and a mouse
model which can dissociate the relative contributions of gonadal
and genetic sex, we examined the possibility that genetic sex con-
trols expression of GABA-related genes and associated anxiety-
and depressive-like behaviors.
MATERIALS AND METHODS
HUMAN SUBJECTS
Brain samples were obtained after consent from next-of-kin dur-
ing autopsies conducted at the Allegheny County Medical Exam-
iner’s Office (Pittsburgh, USA) using procedures approved by Uni-
versity of Pittsburgh’s Institutional Review Board and Committee
for Oversight of Research Involving the Dead. Consensus DSM-IV
diagnoses were made by an independent committee of experienced
clinical research scientists using information from clinical records,
toxicology results, and a standardized psychological autopsy (23).
META-ANALYSIS OF SST GENE EXPRESSION IN MDD DATASETS
Subjects
A total of 51 subjects with MDD and 50 control subjects were
included in the eight studies. DLPFC, subgenual ACC (sgACC),
or rostral amygdala samples enriched in lateral, basolateral, and
basomedian nuclei had been previously collected. Two studies
were performed in DLPFC, four studies in sgACC, and two studies
in amygdala. Half of the studies had been performed in female
subjects in each brain region. Details on all subjects, areas inves-
tigated, and subject parameters are available in Table 1. Group
means for age, postmortem interval (PMI), RNA integrity num-
ber (RIN; measured by Agilent Bioanalyzer; Santa Clara, CA, USA),
and brain pH were nearly identical and not statistically different
for all studies. Details on each cohort were previously reported
[DLPFC (22), sgACC (21), amygdala (16)].
Quantitative real-time PCR validation of microarray meta-analysis
Quantitative real-time PCR (qPCR) results for SST from indi-
vidual published studies on the DLPFC (22), sgACC (20, 21),
amygdala (16) were combined by Stouffer’s Z-trend meta-analysis.
Briefly, mean SST expression in control subjects was set at 100%
expression, and mean SST expression in MDD subjects was
expressed as a percentage of control expression. To calculate the
mean and standard error for SST across areas, the weighted aver-
ages (based on N in each study) for each study were combined.
Meta P software (24) was then used to combine p-values for each
individual study. Stouffer’s Z-trend p-values are reported, which
take into account p-values, the sample size of each individual study
and the direction of effect.
GENE NETWORKS AND EXPRESSION QUANTITATIVE TRAIT LOCI
Subjects
A total of 214 control individuals (no DSM-IV diagnosis) were
used in this study (see Table 2 for technical variables of cohort).
Upon brain collection,∼2 cm coronal blocks from the right hemi-
sphere were cut through the rostro-caudal extent of the brain and
stored at −80°C. The RIN of each brain was assessed by chro-
matography (Agilent Bioanalyzer; Santa Clara, CA, USA). Samples
were obtained from two prefrontal cortex regions: Brodmann areas
(BA) 11 and 47. Detailed information on gene arrays, expression
measures, and genotyping is included in Appendix.
Functional and network analysis using Ingenuity Pathway Analysis
For BA11 and BA47 separately, Pearson correlation values were
calculated between SST and each transcript examined by microar-
ray. These correlation with SST values were highly similar across
regions (R> 0.95), thus the brain region-specific correlation val-
ues were averaged to get correlation with SST across brain regions.
Analysis was performed for the top 200 genes positively correlated
with SST (R> 0.725) in the gene expression dataset from 214 con-
trol subjects (no DSM-IV diagnosis; BA11, BA47), to investigate
biological pathways potentially affected by SST. Genes selected
were overlaid onto the global molecular network of ingenuity
pathway analysis (IPA) (Ingenuity® Systems, www.ingenuity.com),
a database of over 3.5 million literature-based links between genes
and other bioactive molecules. IPA© creates networks based on
literature-based evidence for functional links between genes.
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Table 1 | Data description of eight MDD microarray studies used for meta-analysis of SST results.
Study name Sex Brain region Sample size Array platform Covariates for SST
MD2_DLPFC_M Male DLPFC 32 (16 pairs) Affy. HG-U133 Plus 2 Age, PMI
MD1_ACC_M Male ACC 30 (15 pairs) Affy. HG-U133 Plus 2 Age
MD2_ACC_M Male ACC 18 (9 pairs) Affy. HG-U133 Plus 2 None
MD1_AMY_M Male AMY 28 (14 pairs) Affy. HG-U133 Plus 2 Age
MD2_DLPFC_F Female DLPFC 28 (14 pairs) Affy. HG-U133 Plus 2 Age, PMI
MD3_ACC_F Female ACC 28 (14 pairs) Illumina HumanHT-12 Age, RIN
MD2_ACC_F Female ACC 22 (11 pairs) Illumina HumanHT-12 Alcohol, suicide
MD3_AMY_F Female AMY 42 (21 pairs) Illumina HumanHT-12 Age, suicide
ACC, anterior cingulate cortex; AMY, amygdala; DLPFC, dorsolateral prefrontal cortex; PMI, postmortem interval; RIN, RNA integrity number. Note that some subjects
are included in multiple studies (i.e., more than one brain region investigated for some subjects). We accounted for this putative dependence structure by keeping
the same permutation order for each pair of studies of the same cohort in the permutation analysis of individual studies.
Table 2 |Technical variables for human postmortem brains used in QTL
and gene network analyses.
Variable N (%) or mean (SD)
Age, years 50.8 (14.9)
Range 16–96
Sex
Male 167 (79)
Female 44 (21)
Race
Caucasian 180 (85)
African-American 31 (15)
PMI 17.2 (5.9)
Range 4.8–37.5
pH 6.7 (0.3)
Range 5.8–7.6
RIN 8.0 (0.73)
Range 5.9–9.6
PMI, postmortem interval; RIN, RNA integrity number.
GABA-signaling-related gene network
Genes related to GABA-signaling (e.g., GABA receptor subunits,
markers of GABA neurons) were selected to build a weighted
gene co-expression network. Two genes or transcripts are con-
sidered co-expressed if their patterns of expression are correlated
across samples; this link has been shown to reflect shared function,
through multiple potential biological pathways, including com-
mon regulatory pathways (e.g., hormone signaling, transcription
factors) (25). Here, we only considered expression data from BA11.
Pearson correlation values were calculated between individual
GABA-signaling-related gene and every other GABA-signaling-
related gene to create a co-expression table. Pearson correlation
values greater than 0.5 were then used to create a weighted gene
co-expression network that was visualized in Cytoscape (2.8.3).
Trans-eQTL
We focused on genetic variation on the X-chromosome to iden-
tify single nucleotide polymorphisms (SNPs) associated with
expression of SST and GABA-synthesizing enzymes glutamate
decarboxylase 67 (GAD67 ) and GAD65; since these genes are not
on the X-chromosome, this is considered trans-expression quanti-
tative trait loci mapping. We used samples from white subjects here
(N = 170; 136 males, 34 females; males and females analyzed sep-
arately). Detailed methods for trans-eQTL mapping are included
in Appendix.
Cis-eQTL (association of X-chromosome SNPs with nearby genes)
We then performed cis-eQTL analyses to identify SNPs that are
associated with expression of nearby genes (within 50 kb of genes).
The same samples were used here as for the trans-eQTL stud-
ies (N = 170 white subjects; 136 males and 34 females). SNPs
were selected for this analysis only if they were previously iden-
tified as having significant association with SST, GAD67, and/or
GAD65. In the ANCOVA model, we adjusted for age, brain pH, and
RNA integrity (RIN values), as these three covariates significantly
influenced gene expression in both BA11 and BA47, and detected
whether the identified SNPs altered expression of any nearby tran-
scripts (performed in males and females separately). We did not
control for multiple testing, as we had a priori hypotheses that
these SNPs would alter gene expression. Statistical significance
was set at p< 0.05.
MICE
Four Core Genotypes (FCG; Jackson Labs, Bar Harbor, ME, USA;
B6.Cg-Tg(Sry)2Ei Srydl1Rlb/ArnoJ) mice were used (26). By cross-
ing a C57BL/6J female with an XY−Sry male (Y− denotes absence
of the testis-determining gene, Sry, on the Y-chromosome; Sry
denotes presence of the autosomal testis-determining Sry trans-
gene), four groups of mice are generated: XX gonadal males
(XXSry), XX gonadal females (XX), XY− gonadal males (XY−Sry),
and XY− gonadal females (XY−). Each breeding pair can gener-
ate all four genotypes, eliminating any possible litter effects. Due
to the genetic manipulation, cages of gonadal females contained
both XX and XY− mice, and cages of gonadal males contained
both XXSry and XY−Sry mice. All mice were maintained in group
housing (separated by gonadal sex) under standard conditions
(12/12 h light/dark cycle, 22± 1°C, food and water ad libitum;
same room) in a pathogen free animal facility, in accordance with
the University of Pittsburgh Institutional Animal Care and Use
Committee. Note that cages contained standard bedding material,
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with no additional enrichment. The University of Pittsburgh is
fully accredited by the American Association for Accreditation of
Laboratory Animal Care (AAALAC).
EXPERIMENTAL DESIGN FOR MOUSE STUDIES
Refer to Figure 1. Numbers of mice per group are in Table 3
(N = 50–60 mice/main factor). FCG mice were un-manipulated
until gonadectomized (GDX) at 15 weeks. Half the mice from each
genotype were implanted with testosterone-filled capsules and half
with blank capsules (to investigate activational effects of circu-
lating testosterone); cages of group-housed mice were randomly
assigned to receive either blank or testosterone-filled capsules so
as to create similar numbers of blank and testosterone-treated
mice for each genotype. After allowing 3 weeks for hormone lev-
els to equilibrate, mice were tested in the elevated plus maze
(EPM) and open field (OF) to investigate baseline anxiety-like
behaviors. All mice were then exposed to 7 weeks of unpredictable
chronic mild stress (UCMS), a paradigm that robustly increases
anxious/depressive-like behaviors, thus presenting homologous
features to human depressive-like symptoms (27). During UCMS
weeks 5–7, animals were exposed to the EPM and OF to investigate
stress-induced anxiety-like behaviors, and sucrose preference for
anhedonia-/depressive-like behavior. During all behavior testing,
experimenters were blind to genotype and hormone-treatment
groups. A longitudinal study (i.e., baseline behavior followed by
UCMS exposure followed by post-UCMS behavior) was employed
due to experimental constraints on the number of animals that can
be used in a UCMS/behavior study, since the focus of the exper-
imental contrasts were on group differences under baseline and
high emotionality states. The EPM, OF, and sucrose preference
tests were selected to examine anxiety- and depressive-like behav-
ior in mice. The pharmacological validation of these tests using
known antidepressant and anxiolytic compounds has been exten-
sively characterized [reviewed in (28–30)]. Mice were sacrificed
and brains used for real-time quantitative PCR analysis of Sst,
Gad67, and Gad65 gene expression.
GONADECTOMY AND HORMONE-TREATMENT
Under isoflurane anesthesia, 15-week-old mice were bilaterally
GDX to remove endogenous, gonadal sources of hormones. GDX
animals received a subcutaneous SILASTIC (Dow Corning Corp.,
Midland, MI, USA) capsule containing 5 mm crystalline testos-
terone (1.57 mm ID× 2.41 mm OD), while the other half received
blank capsules (N = 12–20 mice/group; N = 50–63/main effect).
This size testosterone capsule yields circulating testosterone levels
at or slightly above normal male levels. At the time of sacrifice, we
collected trunk blood for testosterone assay to confirm the efficacy
of our adult hormone manipulation. Serum samples were sent
to the University of Virginia Center for Research in Reproduction
Ligand Assay and Analysis Core (supported by the Eunice Kennedy
Shriver NICHD/HIH (SCCPIR) Grant U54-HD28934) and RIA
was used to determine testosterone concentration. Groups treated
with testosterone capsules did not differ in serum testosterone
levels (p> 0.4).
UNPREDICTABLE CHRONIC MILD STRESS
UCMS replicates the role of stress in eliciting MDD, models several
MDD symptom dimensions, and respects the timeframe of onset
FIGURE 1 | Experimental design and sex-related factors. FCG mice were
gonadectomized (GDX) at approximately 15 weeks old and implanted with
either testosterone (T)-filled or blank capsules. After allowing 3 weeks for
animals to recover from surgery, all mice were exposed to behavioral tests
to assess baseline (“non-stress”) anxiety-like behavior and activity. Mice
were then exposed to 7 weeks of unpredictable chronic mild stress
(UCMS). During weeks 6 and 7 of UCMS, mice were exposed to behavioral
tests to assess chronic stress-induced anxiety-like and
anhedonia-/depressive-like behavior and activity. Sex-related factors are
shown at the bottom to indicate windows of time in which genetic sex,
gonadal sex, and/or circulating hormones can act.
Table 3 |Treatment and size of experimental groups.
Genotype Genetic
sex
Gonadal
sex
Activational
group
Baseline
N
Post-UCMS
N
XX Female Female GDX+blank 14 13
GDX+T 20 20
XXSry Female Male GDX+blank 17 17
GDX+T 15 14
XY− Male Female GDX+blank 13 13
GDX+T 13 13
XY−Sry Male Male GDX+blank 12 12
GDX+T 15 14
GDX, gonadectomy; T, testosterone.
and efficacy of antidepressant treatment (29). Briefly, the UCMS
protocol consisted of a 7-week period during which group-housed
mice were exposed to a randomized schedule of environmental
disturbances approximately 1–2 times per day, 7 days a week, as
applied in our lab (29, 31, 32). Disturbances included forced bath
(∼2 cm of water for 15 min), aversive smell (1 h exposure to bobcat
urine), light cycle reversal or disruption, social stress (rotate mice
into previously occupied cages), tilted cage (45°tilt), mild restraint
(50 ml conical tube with air hole for 15 min), bedding change
(replace soiled bedding with clean bedding), wet bedding, and no
bedding. Weekly assessment of weight and fur were performed to
track progression of the UCMS syndrome [as in (29)].
BEHAVIORAL TESTING
Elevated plus maze
Behavior in the EPM was measured during the light phase as pre-
viously described (33) using a cross maze with 2 open and 2 closed
30 cm× 5 cm arms. Time spent and percent entries (entries into
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open arms divided by entries into open or closed arm× 100) in
the open arms were recorded for 10 min to measure anxiety-like
behavior. The total number of entries into any arm was used as an
index of locomotor behavior.
Open field
The OF test was performed during the light phase in a
50.8 cm× 50.8 cm arena, and the center of the OF was defined as
the centermost 25.4 cm× 25.4 cm of the arena. ANY-Maze soft-
ware (Stoelting; Wood Dale, IL, USA) was used to track behavior
that was recorded using a ceiling-mounted video camera. The time
spent and percent distance (distance in center divided by total dis-
tance× 100) in the center of the arena were recorded for 10 min as
measures of anxiety-like behavior. The total distance traveled was
recorded as an index of locomotor activity.
Sucrose preference
During training for sucrose preference, group-housed mice have
free access to both water and a 2% sucrose solution for 48 h to
reduce neophobia. After the initial 24 h of training, the orienta-
tion of the sucrose and water bottles is switched so that the mice
do not learn to associate the sucrose with a particular location
relative to the water filled bottle. Following training, mice were
single-housed in a new cage for 16 h (during the dark phase) and
given free access to both water and 2% sucrose; amount water and
amount sucrose were recorded. Sucrose intake as a percentage of
total volume of fluid consumed denotes sucrose preference. Due
to experimental constraints, only half the mice from each group
(n= 60 total) were exposed to the sucrose preference test.
FRONTAL CORTEX DISSECTION GENE EXPRESSION ANALYSIS
Brains from the mice used in behavioral analysis were flash frozen
on dry ice at the time of sacrifice (after 7 weeks UCMS and while
still being exposed to stressors) and stored at−80°C. One-hundred
and sixty micrometer thick rostro-caudal sections were obtained
using a cryostat and a 1 mm bore tissue punch was used to iso-
late the frontal cortex [cingulate cortex and prelimbic cortex;
between Bregma +2.34 and +0.50 mm; (34)]. cDNAs were gen-
erated from RNA extracted from frontal cortex tissue punches.
Using qPCR we examined the expression of three genes associ-
ated with cortical GABA microcircuitry: two genes coding for
GABA-synthesizing enzymes (Gad67, Gad65), and Sst, a marker
of dendritic-targeting GABA neurons. Detailed information on
qPCR methods is included in Appendix.
STATISTICAL ANALYSIS
As previously described for FCG mice (35), we used three-way
ANOVA (gonadal sex-by-adult testosterone-treatment-by-genetic
sex) to compare groups for each dependent measure (behavioral,
gene expression). The genetic sex effects were examined by com-
paring XX to XY− mice. Gonadal sex effects were analyzed by
comparing mice with ovaries (XX, XY−) to those with testes
(XXSry, XY−Sry); since all mice were GDX several weeks prior
to behavioral testing, any differences observed due to gonads are
considered to be organizational effects (permanent changes due
to hormone exposure during a critical developmental period). To
examine effects of adult testosterone exposure, we compared mice
GDX in adulthood and implanted with testosterone-filled capsules
to those GDX and implanted with blank capsules; these are con-
sidered to be activational effects of testosterone. If the three-way
ANOVA was significant for any main effect or interaction, we per-
formed planned contrasts using Tukey’s post hoc test. Data are
expressed as mean± SEM and statistical significance was set at
p< 0.05, and trend-level at p< 0.1.
RESULTS
SEX-SPECIFIC REDUCTION OF SST IN MAJOR DEPRESSION
We first systematically investigated prior reports suggesting a
greater down-regulation of SST in female MDD (21). Using meta-
analysis of eight human postmortem microarray studies across
corticolimbic brain regions (DLPFC, ACC, AMY; Table 1) [see
(36, 37)], we confirmed that SST was decreased in subjects with
MDD compared to controls; however when males and females
were considered separately, the SST reduction was significant in
females, but not males. Using meta-regression, we confirmed that
the low SST findings in female MDD was significantly different
from results in male MDD (Figure 2), together demonstrating
a sexual dimorphism in reduced SST in MDD. We confirmed
these results with meta-analysis of SST qPCR results from multiple
studies, across multiple brain regions. In the DLPFC (Figure 3A),
SST is significantly down-regulated in males and females sep-
arately, as well as when males and females are combined. In
the sgACC (Figure 3B) SST is significantly down-regulated in
males and females separately, as well as when males and females
are combined. In the amygdala (Figure 3C), SST is significantly
down-regulated in females, but not males. When qPCR results
are combined by meta-analysis across areas (Figure 3D), the
SST down-regulation is more robust in females (−33%) than in
males (−19%).
SST -BASED GENE NETWORK ANALYSIS IN HUMAN FRONTAL CORTEX
To assess the biological context of SST, we next aimed to identify
genes co-expressed with SST. In a large cohort of 214 control sub-
jects (Table 2), we identified the top 200 genes positively correlated
with SST (Table 4). Pathway analysis identified GABA receptor
signaling and mitochondrial dysfunction as the top canonical
pathways represented (Table 5). Notably, this SST -co-regulated
gene selection included GAD67 and GAD65. To further assess the
specificity of these links, we built a weighted gene co-expression
network restricted to GABA-signaling genes (e.g., receptor sub-
units, GABA neuron markers), which confirmed the tight co-
regulation between SST, GAD67, and GAD65, as illustrated by their
close proximity in the network graph (Figure 4), demonstrating
that they form a tightly linked biological module, and suggesting
common upstream regulating factors. Based on these results and
on evidence of down-regulation in MDD (20), all further analyses
focused on these three genes.
ASSOCIATION OF SST, GAD67, AND GAD65 EXPRESSION WITH
X-CHROMOSOME GENETIC VARIANTS IN HUMANS
To test the hypothesis of X-chromosome genetic contribution to
SST, GAD67, and GAD65 gene expression, we performed an eQTL
study in the same postmortem dataset. Since SST, GAD67, and
GAD65 are not located on the X-chromosome, the assumption
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for an X-chromosome contribution to the expression of those
genes is through trans-regulation by X-chromosome-encoded
factors (trans-eQTL). After Benjamini Hochberg correction for
X-chromosome SNPs (38), 165 X-chromosome SNPs remained
FIGURE 2 | Somatostatin (SST) expression is more robustly
down-regulated in women with MDD. Results from eight microarray
studies [MDD subjects (N =52) versus controls (N =51)] were combined
by meta-analysis. Two studies were performed in dorsolateral prefrontal
cortex (DLPFC), four in anterior cingulate cortex (ACC), and two in amygdala
(AMY). Half of the studies were performed in female subjects in each
region. X -axis indicates effect of MDD. The left-hand columns list the
names of the studies and the effect size values. The summary effect of
each study is depicted as a point estimate (mean effect size) bounded by its
95% confidence interval (±1.96 standard deviation), represented by
horizontal lines. The summarized effect is plotted as a diamond, which is
shown on the bottom line with the associated REM p-value. The lack of
overlap with the vertical no-effect line (effect size=0) for the summarized
diamond indicates statistical significance of the meta-analysis.
significantly associated with expression of SST, GAD67, and/or
GAD65 (Table 6), identifying 44 X-chromosome transcripts
(Table 7). Fifty-nine of these SNPs appeared functional as demon-
strated by significant associations with altered expression of these
X-transcripts (cis-eQTL; indicated in bold in Table 7). In con-
trast, two genes chosen for no co-expression with SST (KDM5C
and C2orf49) displayed no significant X-chromosome SNPs. Of
the 27 Y-chromosome SNPs genotyped, none were associated
with gene expression of SST, GAD67, or GAD65. Together, these
results “link” SST, GAD67, and GAD65 to X-chromosome fac-
tors, supporting our central hypothesis of sex chromosome medi-
ated control of GABA-related genes and associated affect regu-
lation. The number of identified SNPs and sexually dimorphic
trans-eQTL results (Table 6) suggest that gonadal hormones
may play an intermediary role; in other words, our results sug-
gest that gonadal hormones (which are different between males
and females) could override or modulate gene expression that is
regulated by X-chromosome SNPs.
XY GENETIC SEX DECREASES GABA-RELATED GENE EXPRESSION
Refer to Table A1 in Appendix for summary of statistical results.
Since it is impossible to separate the role of genetic sex from
gonadal sex in humans, as gonadal sex is determined by genetic
sex, the X-chromosome trans-eQTL results could reflect indirect
hormonal effects. We tested this hypothesis using the FCG mouse
model, in which genetic and gonadal sex are artificially decou-
pled. In this model, the testes-determining gene, Sry, was removed
from the Y-chromosome and placed on an autosome, hence yield-
ing XX mice with either ovaries or testes, and XY mice with
either ovaries or testes (39). We assessed gene expression in the
FIGURE 3 | qPCR validation of microarray meta-analysis. Individual qPCR results in the dorsolateral prefrontal cortex (DLPFC) (A), subgenual anterior
cingulate cortex (B), and amygdala (C). (D) When individual qPCR results are combined by meta-analysis, females have a much more robust down-regulation of
SST expression than males. *p<0.05; **p<0.01; ***p<0.001; ns, not significant.
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Table 4 |Top 200 genes correlated with SST in human frontal cortex.
ABI2, ACOT7, ACP1, ACTR3B, AP2S1, APITD1-CORT, APOA1BP, ARL4C,
ARPC2, ARPC4, ATOX1, ATP5B, ATP5G1, ATP5I, ATP6V0B, ATP6V0D1,
AZIN1, BRP44, BSCL2, C12orf10, C12orf68, CA10, CACNG3, CADM3,
CALB1, CBLN4, CDH13, CDH8, CDK5, CDK5R2, CHCHD6, CHP, CISD1,
CLIP3, CMAS, COMMD7, COPS4, CORO1A, COX8A, CRHBP, CRYM,
CSNK2A1, CUTA, CYC1, DCTN3, DCTPP1, DDT, DLG3, DLG4, DUSP3,
EFNB3, EIF3K, FABP3, FKBP1A, GABBR2, GABRA3, GABRA5, GABRB3,
GAD67, GAD65, GGCT, GHITM, GLCE, GNG3, GRIA1, GRIK1, HMP19,
HN1, HPCA, IGF1, ITPKA, LANCL2, LCMT1, LPPR4, LUZP6, MAGED1,
MAGEH1, MAL2, MAST3, MDH2, MFSD4, MGST3, MIF, MMD, MRPL28,
MRPL37, MRPL55, MRPS24, NCAM2, NDUFA11, NDUFA9, NDUFAB1,
NDUFB5, NDUFS3, NDUFS6, NDUFV1, NECAP1, NHP2, NNAT, NPTXR,
NRIP3, NRN1, NRSN2, NUS1, NXPH1, OLFM1, OXCT1, PAFAH1B1,
PCDH20, PGAM1, PGAM4, PIH1D1, PINK1, PLD3, PNMA1, PNOC,
PPP5C, PRAF2, PRKCB, PSMA5, PSMA7, PSMB3, PSMB5, PSMB6,
PSMB7, PSMC3, PSMD8, PTPRN, PTS, RAB27B, RAB3A, RAB3B,
RAB3C, RAB6A, RBP4, RFK, RGS7BP, RHBDD2, RHEB, RNASEK, RNF11,
ROBO2, RPH3A, SCAMP5, SCG2, SCG5, SCN3B, SERINC3, SEZ6,
SEZ6L2, SF3B5, SLC17A7, SLC25A3, SLC25A4, SLC25A46, SLC2A13,
SLC32A1, SLC35B1, SNRPD2, SPAG7, SPHKAP, SPINT2, SSBP2, STK25,
STMN2, SUB1, SVOP, SYNPR, SYT5, TAC1, TAGLN3, TBC1D9, TBCB,
TM9SF2, TMEFF2, TMEM141, TMEM160, TMEM203, TMEM205,
TMEM208, TMEM59L, TMSB10, TOLLIP, TRAPPC2L, TTC9B, TUBA1A,
TUBA4A, TUBB, TXNL4A, UBE2S, UQCR11, UQCRFS1, UQCRH, VAMP2,
VBP1, XKR4, YWHAG, ZCCHC12, ZCCHC17, ZNF385D
frontal cortex, as this region includes the homolog of the ACC in
humans, a corticolimbic region affected in MDD (20, 21). Main
factor analyses revealed a significant effect of genetic sex, with
reduced expression of Sst, Gad67, and Gad65 in XY compared to
XX mice, regardless of gonadal sex or adult testosterone expo-
sure (Figures 5A–C). No gonadal sex or testosterone-treatment
effects, or interactions between any main factors were observed
on expression levels; thus, we represent the results as main factors
(Figures 5A–C). Differences in earlier circulating testosterone lev-
els in XX and XY mice (i.e., before gonadectomy) were unlikely
to explain the differences, as prior studies report no peripubertal
hormone differences (40) or adult testosterone level differences in
FCG mice (41, 42). These results confirm in mice the contribu-
tion of genetic sex to Sst, Gad67, and Gad65 expression suggested
by the human studies. However, the lower expressions in genetic
male mice were surprising since our human findings indicated
low SST in women with MDD, suggesting that the effect of male
genetic sex may be opposed by other factors in “intact” human
males, potentially testosterone, since prior studies suggest that it
can lower anxiety (43).
ANXIETY-LIKE BEHAVIORS ARE INCREASED BY XY GENETIC SEX AND
DECREASED BY CIRCULATING TESTOSTERONE IN MICE
Refer to Table A2 in Appendix for summary of statistical results.
To investigate whether testosterone could play a compensatory
role to lower anxiety in males, we analyzed anxiety-/depressive-
like behavior in FCG mice under baseline “non-stress” conditions
and after exposure to UCMS. UCMS is a behavioral paradigm that
robustly increases behavioral emotionality, thus presenting some
homologous features associated with human depression (although
not “modeling” this complex human disorder, but providing criti-
cal information about response to chronic stress) (27). There were
no significant interactions of main factors in the EPM or OF, and
results are displayed as main effects (Figures 6 and 7). These mea-
sures were controlled for locomotor activity, which independently
displayed effects of sex-related factors (see below; Figure 8).
Genetic sex
Contrary to our prediction, but consistent with reduced expres-
sion of Sst, Gad67, and Gad65 (Figure 5), XY mice, regardless of
gonadal sex or adult testosterone exposure, consistently exhibited
higher anxiety-like behaviors than XX mice. In the EPM at base-
line, XY mice spent significantly less time (Figure 6A left) and had
lower percent crosses into the aversive open arms (Figure 6B right)
than XX mice. Baseline results in the OF were consistent with the
EPM results, with XY mice exhibiting lower percent distance in the
aversive center of the OF (Figure 6B right) than XX mice, together
providing converging evidence indicative of elevated anxiety-like
behaviors in XY mice at baseline. Behavioral results after pro-
longed exposure to UCMS were consistent with baseline results.
XY mice spent less time in the open arms (Figure 7A left), had
lower percent crosses into the open arms of the EPM (Figure 7A
right), and had trend-level lower percentage distance in the center
of the OF (Figure 7B right). There was no main effect of genetic
sex on percent sucrose consumed in the sucrose preference test
(Figure 7C left).
Adult testosterone-treatment
As predicted, mice exposed to the activational effects of testos-
terone in adulthood (similar to levels of a normal male) exhib-
ited lower adult anxiety-like behavior, regardless of genetic sex
or gonadal sex. At baseline, mice treated with testosterone had
trend-level elevated percent distance in the center of the OF
(Figure 6B right). The activational effects of testosterone were
more robust after UCMS. Testosterone-treated mice spent more
time (Figure 7A left) and had higher percent crosses into the open
arms of the EPM (Figure 7A right), and spent more time in the
center of the OF (Figure 7B left). There was no main effect of cir-
culating testosterone on percent sucrose consumed in the sucrose
preference test (Figure 7C left).
Gonadal sex
Gonadal sex had inconsistent effects on anxiety-like behavior:
mice with testes (and therefore testosterone) during development
(gonadal males) exhibited a trend for more time in the open
arms of the EPM at baseline (Figure 6A left; lower anxiety-like
behavior). After UCMS, gonadal males showed a trend for less
time and percent distance in the center of the OF (Figure 7B;
higher anxiety-like behavior) than gonadal females. While gonadal
sex had minimal effects on anxiety-like behavior, it was the
only main factor influencing anhedonia-/depressive-like behav-
ior, as gonadal males exhibited increased sucrose preference
(Figure 7C left). In line with the well-established concept
that organizational effects during development create differ-
ences in how the adult brain responds to hormones (39),
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Table 5 | (Top) Mitochondrial dysfunction-related genes with expression correlated with SST (14/174 genes) in human frontal cortex. (Bottom)
GABA receptor signaling-related genes with expression correlated with SST (8/56 genes).
Gene symbol Gene title Gene accession Correlation with SST (R)
ATP5B ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide NM_001686 0.759
COX8A Cytochrome c oxidase subunit VIIIA (ubiquitous) NM_004074 0.771
CYC1 Cytochrome c-1 NM_001916 0.748
NDUFA9 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39 kDa NM_005002 0.742
NDUFA11 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7 kDa NM_175614 0.755
NDUFAB1 NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8 kDa NM_005003 0.788
NDUFB5 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5, 16 kDa NM_002492 0.736
NDUFS3 NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30 kDa (NADH-coenzyme
Q reductase)
NM_004551 0.735
NDUFS6 NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13 kDa (NADH-coenzyme
Q reductase)
NM_004553 0.767
NDUFV1 NADH dehydrogenase (ubiquinone) flavoprotein 1, 51 kDa NM_007103 0.754
PINK1 PTEN induced putative kinase 1 NM_032409 0.74
UQCR11 ubiquinol-cytochrome c reductase, complex NM_006830 0.735
UQCRFS1 ubiquinol-cytochrome c reductase, Rieske NM_006003 0.812
UQCRH ubiquinol-cytochrome c reductase hinge NM_006004 0.777
AP2S1 adaptor-related protein complex 2, sigma 1 subunit NM_004069 0.78
GABBR2 Gamma-aminobutyric acid (GABA) B receptor, 2 NM_005458 0.75
GABRA3 Gamma-aminobutyric acid (GABA) A receptor, alpha 3 NM_000808 0.73
GABRA5 Gamma-aminobutyric acid (GABA) A receptor, alpha 5 NM_000810 0.746
GABRB3 Gamma-aminobutyric acid (GABA) A receptor, beta 3 NM_021912 0.748
GAD67 Glutamate decarboxylase 67 (brain, 67 kDa) NM_000817 0.736
GAD65 Glutamate decarboxylase 65 (pancreatic islets and brain, 65 kDa) NM_000818 0.791
SLC32A1 Solute carrier family 32 (GABA vesicular transporter), member 1 NM_080552 0.773
testosterone decreased anhedonia-/depressive-like behavior in the
sucrose preference test in gonadal males (Figure 7C right);
this result is consistent with the frequent observation that
gonadal males and females respond differently to adult hor-
mone manipulations [e.g., (9, 44)], indicating that hormone-
treatments that influence mood in men could affect women
differently.
LOCOMOTOR ACTIVITY IS DECREASED BY XY GENETIC SEX AND
INCREASED BY CIRCULATING TESTOSTERONE
Refer to Table A3 in Appendix for summary of statistical results.
There were no significant interactions of main factors in the EPM
or OF, and results are displayed as main effects (Figure 8).
Genetic sex
XY mice exhibited lower baseline activity than XX mice, as indi-
cated by fewer total crosses the EPM (Figure 8A) and less total
distance traveled in the OF (Figure 8B). After chronic stress, XY
mice had fewer total crosses in the EPM (Figure 8C), consistent
with reduced activity.
Adult testosterone-treatment
Testosterone-treatment in adulthood resulted in increased base-
line activity, with testosterone-treated mice having more crosses
in the EPM (Figure 8A) and more total distance traveled in the
OF (Figure 8B). Testosterone-treated mice also had higher activity
after UCMS, with greater total EPM crosses (Figure 8C) and more
total distance traveled in the OF (Figure 8D).
Gonadal sex
Gonadal sex had a slight effect on activity, as gonadal males exhib-
ited lower OF total distance after UCMS than gonadal females
(Figure 8D).
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FIGURE 4 | Weighted gene co-expression network of
GABA-signaling-related genes. Genes included in this network are GABA
interneuron markers [somatostatin (SST), parvalbumin (PV), neuropeptide Y
(NPY), calretinin (CR), calbindin (CALB1), vasoactive intestinal peptide (VIP),
cholecystokinin (CCK)], GABA A receptor subunits (alpha 1 (GABRA1), alpha
2 (GABRA2), alpha 5 (GABRA5), and GABA-related genes [GAD67, GAD65,
GABA transporter 1 (GAT1)]. Nearness of nodes is proportional to
co-expression strength. Along with SST, GAD67, and GAD65, genes in the
core module include CALB1, which is often co-localized with SST, and
GABRA5, which is postsynaptic to SST-positive GABA neurons.
Table 6 | Summary of human frontal cortex (BA11/BA47) eQTL results
for females and males.
No. of significant
SNPs
No. of LD blocks
(individual SNPs)
No. of transcripts
identified
FEMALES
SST 87 14 (17) 33
GAD67 30 6 (9) 14
GAD65 91 15 (21) 16
MALES
SST 0 0 (0) 0
GAD67 3 0 (3) 7
GAD65 19 2 (6) 12
GAD65, glutamate decarboxylase 65; GAD67, glutamate decarboxylase 67; LD,
linkage disequilibrium; SNP, single nucleotide polymorphism; SST, somatostatin.
DISCUSSION
Using gene array meta-analysis, we identified a sex-specific effect
on decreased expression of SST in the postmortem brain of MDD
patients, with depressed women exhibiting more robust reduction
in SST gene expression (Figures 2 and 3). We then used a gene
network approach to investigate genes co-expressed with SST, and
identified GABA receptor signaling as a top pathway represented by
SST -co-expressed genes. Based on the tight co-expression between
SST, GAD67, and GAD65 (Figure 4), and on evidence for changes
in expression in MDD (20), we focused our investigations on
those three genes in subsequent analyses. We performed an eQTL
Table 7 | X-chromosome genes identified by trans-eQTL association
with SST, GAD67, or GAD65 in human frontal cortex.
FRMPD4, CTPS2, CALB3, RBBP7 , REPS2 , PRDX4, ACOT9, ARX,
IL1RAPL1, USP9X , ZNF674, CHST7 , SLC9A7 , IGBP1, DGAT2L6 ,
PCDH11X , LHFPL1,AMOT , SLC6A14, CXorf61, IGSF1, MID2 ,TEX13B,
ODZ1, SH2D1A, CDKL5 , CXorf59 , PPP1R2P9, EDA,ACSL4, SMARCA1,
OCRL, MAGEC2, SLITRK4, SPANXN1, SPRY3, WDR40C,WWC3 , CLCN4,
PHEX, VSIG1, PSMD10, ATG4A, COL4A6
Genes that displayed additional significant cis-eQTL are indicated in bold.
study in human postmortem brains to investigate potential mech-
anisms underlying the female-specific decrease in GABA-related
gene expression in MDD, and found multiple SNPs on the X-
chromosome significantly associated with SST, GAD67, and/or
GAD65 expression differences. Using the FCG mice to dissect
the respective contributions of sex-related factors, we then show
that genetic sex (i.e., X/Y-chromosome factors), independent of
gonadal sex or circulating testosterorone, influences expression
of these same genes in pro-anxiety/depression directions (lower
expression in XY) (Figure 5), suggesting a mouse/human con-
served mechanism of SST, GAD67, and GAD65 trans-regulation
by X/Y-encoded genes. Notably, XY mice also demonstrated ele-
vated anxiety-like behaviors (Figures 6 and 7). Treating mice with
adult circulating testosterone levels similar to a normal male had
the expected opposite effect of lowering anxiety-like behaviors,
but had surprisingly no-effect on GABA-related gene expres-
sion. Thus, male genetic sex increased anxiety-like behaviors,
while treatment with male-like levels of testosterone decreased
anxiety-like behaviors.
SEXUAL DIMORPHISM IN LOW SST IN MDD
Previous studies showed decreased SST expression in MDD (16,
20–22), with potential greater effects in women with depression
(21). Using a meta-analysis and meta-regression for sex effect,
we confirmed that SST reduction is significantly more robust in
female MDD (Figures 2 and 3), mirroring the increased female
vulnerability to MDD. SST -positive GABA interneurons prefer-
entially target the dendritic compartment of pyramidal neurons
and contribute to sensory integration and fine-tuning of incoming
information onto pyramidal cells. Combined with results indi-
cating that genetic sex affects SST, GAD67, and GAD65 gene
expression, these findings suggest that genetic sex is a moderating
biological factor influencing the function of a GABA-related mod-
ule. Reduced SST may be a marker of reduced GABA-mediated
dendritic inhibition, the end result being increased activation
of targeted pyramidal cells. As a hub in the corticolimbic net-
work of affect regulation, the sgACC consistently shows elevated
metabolic activity with the induction of depressive state (45, 46),
with metabolic activity returning to normal following antidepres-
sant treatment (46) or deep brain stimulation (47). It should
be noted that elevated sgACC activation is not limited to mood
disorders, nor is the sgACC the only region exhibiting altered
activation in mood disorders; however, this elevated activation
and normalization after different modalities of treatment has
been consistently shown across many studies [reviewed in (48)].
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FIGURE 5 | Expression of GABA-related genes in the frontal cortex of FCG mice. XY mice had lower (A) Sst, (B) Gad67, and (C) Gad65 expression levels
compared to XX mice. Error bars indicated mean±SEM. *p<0.05. Y -axis, truncated arbitrary expression units.
FIGURE 6 | Baseline emotionality measures in FCG mice. (A) Baseline
elevated plus maze (EPM) results for time (left) and percent crosses (right)
into open arms. (B) Baseline open Field (OF) results for time (left) and percent
distance (right) in the center. Numbers at the base of bars indicate group
sizes. Error bars indicated mean±SEM. ***p<0.001, **p<0.01; *p<0.05;
#p<0.1.
Interestingly, evidence suggests that some features of sgACC dys-
function in MDD are sexually dimorphic (49). Hence, reduced
GABA-mediated inhibition onto pyramidal dendrites may under-
lie the increased sgACC activation reported in MDD patients (45)
and restoring dendritic inhibitory function may reduce pyramidal
cell activation and contribute to reduced sgACC activation with
positive treatment response (46, 47). Whether such approaches
may be more effective in female subjects with MDD is not known.
We recently showed that expression of Sst, Gad67, and Gad65 is
dependent upon brain-derived neurotrophic factor (BDNF) sig-
naling (16, 20), and reports also indicate sexually dimorphic effects
of reduced BDNF signaling on anxiety-/depressive-like behaviors
(50–52). Combined with evidence that GABA-signaling influences
emotionality (18), it is possible that the sexually dimorphic effect
of BDNF signaling on anxiety-depressive-like behavior could be
mediated through effects on GABA-related gene expression.
SST GENE NETWORK
Pathway analysis of the top SST -co-expressed genes confirmed its
contribution to GABA-signaling and also identified mitochondrial
function as the top associated pathway. Of note, we reported
sex differences in expression of genes related to mitochondrial
function in the amygdala of mice and humans (53). Thus, sex-
dependent differences in mitochondrial function may represent a
potential mediating factor in the male/female differential effects
of MDD in SST cells. Interestingly, we recently found that GAD67
and GAD65 are reduced in the sgACC of male patients with MDD,
but not female patients (20). Combined with our present results
indicating a role for XY genetic sex in decreasing Gad65/67 in a
homologous brain region in the mouse, these results imply that
males may be more likely to have reduced expression of GAD65/67
in the ACC due to genetic sex effects. Interestingly, GAD65/67 and
GABA-related changes were prominent the amygdala of females
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FIGURE 7 | Post-UCMS emotionality measures in FCG mice.
(A) Post-UCMS elevated plus maze (EPM) results for time (left) and percent
crosses (right) into open arms. (B) Post-UCMS open Field (OF) results for
time (left) and percent distance (right) in the center. (C) Post-UCMS sucrose
preference (SP) results for percent sucrose consumed for all groups (left) and
for the organizational × activational interaction (right). Numbers at the base of
bars indicate group sizes. Error bars indicate mean±SEM. ***p<0.001,
**p<0.01; *p<0.05; #p<0.1.
with MDD (16) and not changed in the amygdala of males with
MDD (54), demonstrating both sex- and brain region-specific
contributions to GABA-related MDD pathology.
ASSOCIATION OF X-CHROMOSOME POLYMORPHISMS AND
EXPRESSION OF GABA-RELATED GENES
Since SST, GAD67, and GAD65 are not located on X-
chromosomes, the trans-eQTL results showing association of these
genes with X-chromosome SNPs suggest that the X-chromosome
may contain genes that function as upstream regulators of GABA
gene expression. The large numbers of SNPs with significant
trans-eQTL suggest that these indirect pathways may be com-
plex and include multiple genes and factors. Interestingly, one
of the associated X-chromosome genes was FRMPD4, a positive
regulator of dendritic spine density and morphology, suggest-
ing that FRMPD4 may influence expression of GABA-related
genes through shared downstream biological function related to
neuronal signaling. Another identified X-chromosome gene was
USP9X, a gene that escapes X-inactivation that has been linked to
synaptic development (55). Usp9x expression was also reported
to be higher in genetic female mice compared to genetic males,
regardless of hormone-treatment (56). Of note, the SNPs that
identified FRMPD4 and USP9X were associated with expression
of these genes (cis-eQTL) only in females, suggesting that genetic
variation at these SNPs affect females only, potentially through
sex-specific variations in transcription factor complexes. Alterna-
tively, gonadal hormones could play an intermediary role, either
masking or enhancing genetic sex mediated effects. In contrast
to these X-chromosome indirect effects, circulating testosterone
was not associated with Sst, Gad67, or Gad65 expression in FCG
mice. Hence our results support a contribution of genetic sex
to sexual dimorphism in affect dysregulation in human subjects,
potentially mediated by X-chromosome trans-regulation of key
GABA-related genes.
GENETIC SEX AS A CONTRIBUTING FACTOR
The origin of the effect of genetic sex on GABA-related gene
expression and associated anxiety-like behavior is currently not
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FIGURE 8 | Locomotor activity measures in FCG mice. Elevated plus maze (EPM) results for total crosses at baseline (A) and post-UCMS (C). Open field
(OF) results for total distance at baseline (B) and post-UCMS (D). Numbers at the base of bars indicate N. Error bars indicate mean±SEM. ***p<0.001;
**p<0.01; *p<0.05.
known. Sex chromosomes differ between males and females in the
presence or absence of a Y and the dosage of X-chromosomes. A
role for Y-chromosome genes (other than Sry) would be consis-
tent with reported effects of the Y-chromosome on male repro-
duction (57). Due to random X-inactivation, female tissues are
mosaics, with about half of cells expressing an active maternal
X and the other half expressing an active paternal X. Thus, if
a maternally imprinted X causes increases in gene expression,
XX individuals would have overall lower expression due to the
presence of the paternal imprint in half of the cells. Also, a num-
ber of genes escape X-inactivation (∼15% in humans and ∼3%
in mice, depending on tissue; (58)), and evidence suggests that
“X-escapees” in females could contribute to sexual dimorphism.
For instance, X-chromosome number causes sex differences in
dorsal striatal gene expression (59) and male sex behavior (60)
in mice. Mice that are haploinsufficient for genes escaping X-
inactivation (i.e., XO mice) have higher levels of fear reactivity
compared to XX mice (61). In women with fragile X or Turner
Syndrome (XO), X-haploinsufficiency is associated with elevated
arousal under stressful situations (62). These results from mice and
humans with X-haploinsufficiency mirror our finding of elevated
anxiety-like behavior in XY FCG mice, suggesting that differences
in X-dosage between genetic male and female mice may contribute
to the genetic sex effect on behavioral emotionality reported here.
Follow-up studies in XO and XXY mice may determine if observed
genetic sex effects on anxiety-like behavior and gene expression are
due to X- or Y-linked genes.
OPPOSING EFFECTS OF XY GENETIC SEX AND CIRCULATING
TESTOSTERONE ON ANXIETY
Although reported for the first time for anxiety-like behavior,
one conventional interpretation in the field of sexual dimor-
phism is that male genetic sex exerts a compensatory effect to
reduce behavioral differences otherwise induced by circulating
testosterone (63). Importantly, other studies using FCG mice have
reported opposing actions of male genetic sex and male circulating
hormones. For instance, circulating testosterone has an inhibitory
effect, and XY genetic sex has a stimulatory effect on immune
response (42). Similarly, circulating testosterone increased, and
XY genetic sex decreased the expression of male sex behavior (60).
Thus, the pattern of results we report for anxiety-like behaviors
supports a general hypothesis for a compensatory mechanism
between male genetic sex and testosterone, serving to decrease
differences between males and females (63). Since normal “intact”
male mice exhibit lower emotionality than females (64) and since
we observed a more robust effect of treatment with male-like lev-
els of testosterone on lowering anxiety-like behaviors compared
to the anxiogenic contribution of genetic sex (Figure 7), circu-
lating testosterone seems to “win out” in a normal, intact male;
the end result being males displaying lower anxiety-like behav-
ior. XY genetic male sex also had decreased locomotor activity
(Figure 8), while circulating testosterone had a similar pattern of
opposing this effect. Note that despite controlling the measures
of anxiety-like behaviors for locomotor activity, opposite patterns
are frequently observed and often difficult to dissociate in rodents
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(32). QTL mapping studies have identified chromosomal regions
associated with both anxiety-like behavior and locomotor activity
(65), suggesting epistatic regulation of emotionality and activity
downstream from common genes.
LIMITATIONS
Our gene co-expression and eQTL studies were performed in a
large cohort of control subjects due to the limited number of
postmortem MDD subjects available for genetic analysis. Since we
had an a priori hypothesis for sexual dimorphism, we performed
eQTL analysis only for the X and Y-chromosomes; future unbiased
genome-wide studies may yield additional findings.
FCG mice provide a practical tool for parsing relative contri-
butions of genetic sex, gonadal sex, and circulating hormones to
sexual dimorphism, although there are limitations to this model:
first, XY−mice are not identical to wild-type XY mice, but XY−Sry
male mice are fertile and display no differences from wild-types
in testosterone levels, and serve as the closest equivalent to “nor-
mal” males (40–42). Second, since Sry is also expressed in the
adult mouse brain (66), it may be impossible to separate indi-
rect (through testes development) and direct (through brain gene
expression) effects of Sry. Thus, differences between mice with
and without Sry could be due to direct Sry effects. Additionally,
gene expression could be disrupted after autosomal Sry trans-
gene insertion; although no correlation was observed between Sry
and gene expression. Third, since mice are GDX in adulthood,
this experimental design does not include normal, intact mice.
Finally, genetic and behavioral results in mice may not translate
to humans; however we show that female mice are more suscep-
tible to chronic stress-induced high emotionality (64), suggesting
the approach is appropriate to investigate biological mechanisms
underlying sexual dimorphism in vulnerability to mood disorders.
SUMMARY
In conclusion, these studies provide evidence for more robust
down-regulation of SST in women compared to men with MDD,
and suggest a link between X-chromosomes and sexual dimor-
phism in mood disorders. This link is supported by studies in FCG
mice demonstrating a role for genetic sex in control of Sst, Gad67,
and Gad65 expression, with concomitant effects on behavioral
emotionality. Together, these results support genetic sex as a con-
tributing factor influencing an MDD-related biological module
related to GABA function and mood-related behaviors. Notably,
since related SST /GABA changes are observed in other psychi-
atric and neurodegenerative disorders, this novel finding may have
broader implications for general risk for adult psychopathology
that is linked to genetic sex and GABA function.
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APPENDIX
METHODS
Meta-analysis of SST gene expression in MDD datasets
Gene array data pre-processing. Microarrays were scanned and
summarized by manufacturers’ defaults. Data from Affymetrix
arrays were processed by robust multi-array (RMA) method and
data from Illumina arrays by manufacturer’s BeadArray soft-
ware for probe analysis. Batch effects were evaluated and nor-
malized. Oligonucleotide probes (or probesets) were matched to
gene symbols using hgu133plus2.db and illuminaHumanv4.db
Bioconductor packages.
Meta-analysis using random effect model. Datasets and meta-
analysis methods and results were described previously (36, 37).
Briefly, we adopted linear models to account for potential con-
founding covariates and applied a meta-analysis pipeline to com-
bine eight studies for identification of MDD-associated genes.
Note that some studies were performed in different brain regions
of the same subjects. To account for this putative dependence
structure among studies from the same patients, we kept the same
permutation order for each pair of studies of the same cohort in
the permutation analysis of individual studies. We then used a
random effects model (REM) to detect changes in SST expression
by combining gene effects across all studies.
Meta-regression with variable selection (MetaRG_BIC). We
develop a novel meta-regression framework to investigate across
studies differential effect sizes potentially associated with study-
level variables (i.e., sex/gender; Table 1). Unlike meta-analysis in
clinical or epidemiological research where large numbers of stud-
ies may be available to create a meta-regression model, only a small
number (e.g., 5–15) of studies are available in a common microar-
ray meta-analysis. Since only a very small number (e.g., 0–1) of
variables contribute to the differential effect sizes for a given gene,
we used a variable selection approach here to select appropriate
covariates to use for SST. Specifically, all possible meta-regression
models that include at most one (0 or 1) study-specific variables are
computed and compared. The following meta-regression model
with variable selection is considered:
MetaRG
(
wg
)
: Ygk = µg +
L∑
l = 1
wg1 ∗ βg1 ∗ Xlk + αgk + ηgk,
where Y gk is the effect size for gene g and study k, X lk is the value
for study-level variable l in study k, wgl is the 0–1 weight assigned
to the lth study-level variable (L= 3) and we restrict wgl such
that at most one study-level variable is selected (
∑
l wgl ≤ 1).
We denote by BIC(wg) as the Bayesian Information Criterion
value associated with the meta-regression model MetaRG(wg) and
we search for the best-fit model with the smallest BIC value by
w∗g = (w*g1, w*g2, ..., w*gL) = arg minw∈W BIC(w). Based on the
selected model MetaRG(w∗g ), likelihood ratio test is applied to test
for the βgl with non-zero w
∗
gl (H 0: βgl= 0 versus HA: βgl 6= 0) and
derive the p-value of gene g. This added variable selection avoids
including more than one study-specific variable in the model and
allows assessment of biomarkers related to different study-specific
variable (e.g., gene A might have differential effect size in sex while
gene B might have differential effect size in brain region or plat-
form), which biologically gives a more appealing conclusion and
interpretation. These derived p-values are, however, not the real
p-values for DE gene detection since they are biased from the
variable selection procedure. As a result, we perform a conven-
tional genome-wide permutation test that randomly permutes the
disease labels within each MDD-control pair to generate a null dis-
tribution of individual study effect sizes. We then repeat the above
variable selection procedure to derive the null distribution under
permutation analysis and assess the meta-regression p-value of
each gene.
Forest plots for visualization of meta-analysis findings. A forest
plot is a graphical display designed to illustrate the relative strength
of disease effects across multiple studies addressing the same ques-
tion. The plot shows if the overall effect is based on many studies
or a few, on studies that are precise (study with small variance)
or imprecise (study with large variance), and whether the effects
for all studies tend to line up, or if they vary substantially from
one study to the next. The plot can also highlight anomalies and
outliers.
Gene networks and expression quantitative trait loci
Gene arrays and expression. Total RNA was extracted from
frozen BA11 and BA47 samples stored in TRIZOL and were
processed for microarray analysis using GeneChip Human Gene
1.1 ST from Affymetrix according to manufacturer’s protocol
(http://www.affymetrix.com). Gene expression data was extracted
using Expression Console build 1.2.1.20. The normalization
method is based on quantile normalization to eliminate batch
effects. Data from arrays were processed by RMA method. Gene
expression probes were processed at gene-level and taken in log2
scale for further analysis. After normalization, 33,297 gene-level
probes remained.
Genotyping. All 214 control samples were run on Affymetrix SNP
6.0 arrays for genotyping. Among the 214 samples, 10 RNA sam-
ples did not pass quality control. Genotype calls were generated
using Affymetrix Genotyping Console version 4.1.3. For intensity
quality control, we used Contrast QC, which is the per sample QC
test in the Affymetrix SNP 6.0 intensity array; two samples were
removed after QC. Birdseed v2 algorithm was used for genotyp-
ing, using EM algorithm to drive maximum likelihood fit of two
dimensional Gaussian mixture model.
Trans-eQTL mapping. Single nucleotide polymorphisms were
filtered out using the following criteria: (i) sample missing rate
greater than 10%, (ii) Minor allele frequency (MAF) less than
5%, and (iii) p-value of Hardy-Weinberg equilibrium (HWE) test
less than 10−3 (females only). 24,296 X-chromosome SNPs were
included. In the eQTL model, we adjusted for age, pH, and RIN
values (these three covariates were significantly associated with
gene expression in both BA11 and BA47) since the effects of those
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covariates may confound eQTL findings. The eQTL model with
three covariates for a given genotype:
Gij = α+ γXj +
3∑
k=1
βkSjk+ ∈ij
Gij: gene expression of gene i of subject j
γi: effect of the selected genotype to gene i based on additive
model
Xj: genotype of subject i,0 (homozygous major alleles), 1
(heterozygous calls), and 2 (homozygous minor alleles).
βik: the effect of covariates k; k = 1 (age), 2 (pH), and 3 (RIN) in
gene i
Sjk: the value of covariate k of subject j ; k = 1 (age), 2 (pH), and
3 (RIN)
∈ij∼ N (0, 1)
We used the “Matrix eQTL” R package, a recent computation-
ally efficient package for eQTL analysis (67), to detect the desired
trans-eQTLs.
We applied a meta-analysis method called adaptive weighted
(AW) Fisher’s method to combine the p-values of eQTLs from
two brain regions (BA11 and BA47), since the correlation between
the expression of BA11 and BA47 are high (68). The AW Fisher’s
method assigns different weights (0 or 1) to each eQTL finding
from two brain regions; the testing statistics χ2AW = −
∑2
k=1 Wk ·
log(Pk) , wk= 0 or 1, and it searches through all possible weights to
achieve the best adaptive weight with the smallest p-value. In order
to avoid heterogeneity of eQTL finding across brain regions, we
selected only eQTLs that were identified in both brain regions in
the AW Fisher’s method. The Benjamini Hochberg procedure was
used to control false discovery rate (FDR) of multiple eQTLs (38).
By setting q value 0.05, we detected 87, 30, and 91 trans-eQTLs
of genes SST, GAD67, and GAD65 in female subjects, respectively;
For male subjects, 0, 3, and 20 trans-eQTLs were detected from
genes SST, GAD67, and GAD65, respectively.
Linkage disequilibrium mapping of significant X-chromosome
SNPs. Linkage disequilibrium (LD) is the correlation between
genotypes at different loci in a population. We can use D to quan-
tify LD, which measures how far off genotype frequencies are from
the expectation under no LD. For example, suppose two alleles are
A1, A2, B1, B2, and the frequencies are p1, p2, q1, q2. P11 is the
frequency of A1B1 gametes, P12 is the frequency of A1B2 gametes,
and so on. Define D= P11 – p1 q1, D= 0 if there is no LD. We used
D′=D/Dmax, where
Dmax =
{
max (−p1q1 − p2q2), when D < 0,
min (p1q2, p1q2), when D > 0
Alternatively, we can use correlation coefficient r2, which can
be calculated by
r2 = D
2
p1p2q1q2
The“Haploview”software was used for visualization of D′ (69).
Real-time quantitative PCR
Total RNA was extracted from tissue punches using the All-
prep® DNA/RNA Micro Kit (Qiagen, Valencia, CA, USA) and
assessed using chromatography (Agilent Bioanalyzer; Santa Clara,
CA, USA). RIN was 8.35± 0.04 (mean± SEM), indicating excel-
lent RNA quality. One-hundred nanograms of total RNA was
reverse transcribed into cDNA using QScript cDNA Supermix
[oligo(dT) and random primers (Quanta Biosciences, Gaithers-
burg, MD, USA)]. Small PCR products (70–100 base pairs) were
amplified on a Mastercycler® ep Realplex2 qPCR machine (Eppen-
dorf, Hamburg, Germany), using universal PCR conditions [65–
59°C touch-down and 40 cycles (10 s at 95°C, 10 s at 59°C, and
10 s at 72°C)]. cDNA was amplified in 15µl reactions [0.1X
SYBR-green, 3 mM MgCl2, 200 nM dNTPs, 200 nM primers, 0.25
unit Platinum Taq DNA polymerase (Invitrogen, Carlsbad, CA,
USA)]. Primer-dimers were assessed by amplifying primers with-
out cDNA. Primers were retained if they produced no primer-
dimers or non-specific signal only after 35 cycles. Samples were
run in quadruplicate and results were calculated as the geomet-
ric mean of relative intensities compared to two internal controls
(actin and glyceraldehyde-3-phosphate dehydrogenase). Results
are expressed as the amount of arbitrary signal (2−dCT× 10,000).
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Table A1 | Statistical values associated Sst, Gad67, and Gad65 gene expression in the frontal cortex of FCG mice.
Dependent measure Main genetic effect Main activational effect Main organizational effect
Sst F =4.25; df=1; p<0.045 F =0.08; df=1; p>0.75 F =1.90; df=1; p>0.15
Gad67 F =5.91; df=1; p<0.02 F =0.53; df=1; p>0.45 F =0.30; df=1; p>0.55
Gad65 F =5.61; df=1; p<0.025 F =0.51; df=1; p>0.45 F =0.04; df=1; p>0.80
Gad65, glutamate decarboxylase 65; Gad67, glutamate decarboxylase 67; Sst, somatostatin. Text in bold indicates statistically significant results.
Table A2 | Statistical values associated with baseline (top) and post-UCMS (bottom) emotionality measures in FCG mice.
Dependent measure Main genetic effect Main organizational effect Main activational effect
Baseline Time in open arms (EPM) F =10.11; df=1; p<0.002 F =2.80; df=1; p<0.1 F =0.97; df=1; p>0.3
% Crosses into open arms (EPM) F =5.58; df=1; p<0.03 F =0.60; df=1; p>0.4 F =0.16; df=1; p>0.6
Time in center (OF) F =1.89; df=1; p>0.1 F =2.16; df=1; p>0.1 F =1.95; df=1; p>0.1
% Distance in center (OF) F =8.16; df=1; p<0.01 F =1.58; df=1; p>0.2 F =2.70; df=1; p>0.1
Post-UCMS Time in open arms (EPM) F =7.93; df=1; p<0.007 F =0.20; df=1; p>0.6 F =27.30; df=1; p<0.00001
% Crosses into open arms (EPM) F =5.48; df=1; p<0.03 F =0.09; df=1; p>0.7 F =32.67; df=1; p<0.00001
Time in center (OF) F =0.45; df=1; p>0.5 F =4.19; df=1; p<0.05 F =6.35; df=1; p<0.02
% Distance in center (OF) F =3.35; df=1; p<0.08 F =3.31; df=1; p<0.08 F =1.70; df=1; p>0.1
% Sucrose consumed (SP)1 F =1.22; df=1; p>0.25 F =6.42; df=1; p<0.02 F =1.56; df=1; p>0.20
1There was a significant interaction between organizational and activational effects on percent sucrose consumed (F=5.62; df=1; p<0.025).
EPM, elevated plus maze; OF, open field; SP, sucrose preference. Text in bold indicates statistically significant results.
Table A3 | Statistical values associated with baseline (top) and post-UCMS (bottom) activity measures in FCG mice.
Dependent measure Main genetic effect Main organizational effect Main activational effect
Baseline Total crosses (EPM) F =14.12; df=1; p<0.001 F =1.12; df=1; p>0.2 F =9.21; df=1; p<0.005
Total distance (OF) F =12.86; df=1; p<0.001 F =1.21; df=1; p>0.2 F =13.28; df=1; p<0.001
Post-UCMS Total crosses (EPM) F =7.85; df=1; p<0.007 F =0.094; df=1; p>0.7 F =24.66; df=1; p<0.00001
Total distance (OF) F =1.70; df=1; p>0.1 F =4.12; df=1; p<0.05 F =8.97; df=1; p<0.005
EPM, elevated plus maze; OF, open field. Text in bold indicates statistically significant results.
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